Against a backdrop of achievements yielded from public/private collaborations in the context of the pandemic response, we focused our latest virtual briefing on the crucial role such partnerships play in furthering biopharma and medical devices innovation. We share highlights from the event and provide the catch-up recording in this brief summary.
PMC was delighted to feature in the latest LBIC newsletter from the London BioScience Innovation Centre discussing how the ILAP scheme is helping to secure the UK’s position as a life science superpower. Learn more.
In March 2021, the government published its document Saving and Improving lives: The Future of Clinical Research Delivery. The paper laid out an ambitious vision for a more patient-centred, pro-innovation and data-enabled clinical research environment in the UK. Following the publication of the implementation plan in June, we summarise the key themes in this article.
Join PMC for our next virtual breakfast briefing on Wednesday 21st July 2021 at 8am. Our topic for this session is “The role of public/ private collaborations to further biopharma and medical devices innovation”. We are delighted to welcome Nicki Bromwich, Chief Operating Officer of MedCity who will join Dr Malcolm Barratt-Johnson, Managing Director of PMC to discuss the ecosystem of public/ private collaboration and how it supports innovation. Read more and register.
The MHRA's recently launched Innovative Licensing and Access Pathway scheme (ILAP) forms part of a bold vision for the UK to incentivise and support life sciences development as we emerge into a post-Brexit regulatory and clinical trials environment. PharmaMedic Consultancy is currently supporting several clients with their applications, and in this article, we share more insights about the scheme and how it stands to benefit patients and sponsors.
We were exceptionally proud to sponsor a session at the ABPI conference last week at such a critical juncture for the UK pharmaceutical industry. The speakers, including Matt Hancock, Dr June Raine and Professor Sir John Bell, provided inspiration and food for thought- we certainly feel optimistic about the future of the UK as a life sciences powerhouse. To read our event summary, click here.
As 2021 gets underway, in the context of continued pandemic response and post-Brexit environment, the role of regulatory affairs in pharma is likely to be more instrumental than ever. In this article, we share a preview of the key regulatory trends that Dr Zubair Hussain will discuss at our upcoming breakfast briefing on the 10th February. Read on to learn more about the ways regulatory affairs is set to underpin innovation and sign up to attend our virtual briefing.
Like all sectors, the pharmaceutical industry is facing an unparalleled period of uncertainty. As experienced pharmaceutical consultants, we are well equipped to adapt, thrive and add value in this changing environment. In this article, we explore some of the skills and qualities that we need to embrace now more than ever.
PharmaMedic's VirtualPharma™ Solution is backed by decades of medical affairs experience and built on four key pillars. Read more to learn how we help pharma and biotech companies of all sizes with flexible solutions.
